IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.54%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$217M
AUM Growth
+$217M
(+1.5%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
41.84%
Holding
98
New
28
Increased
15
Reduced
17
Closed
18
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$11M |
| 2 |
Elevance Health
ELV
|
$9.19M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.84M |
| 4 |
Gilead Sciences
GILD
|
$4.17M |
| 5 |
Illumina
ILMN
|
$3.51M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.4M |
| 2 |
Cigna
CI
|
$13.7M |
| 3 |
Medtronic
MDT
|
$7.5M |
| 4 |
Baxter International
BAX
|
$7.01M |
| 5 |
Eli Lilly
LLY
|
$5.4M |
Sector Composition
| 1 | Healthcare | 88.35% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
26
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.64M | 1.07% |
150,000
+75,000
| +100% | +$1.32M |
|
|
TVTY
27
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.6M | 1.06% |
225,000
| – | – |
|
|
KITE
28
DELISTED
Kite Pharma, Inc.
KITE
| $2.5M | 1.02% |
50,000
| – | – |
|
29
Boston Scientific
BSX
$156B
| $2.34M | 0.95% |
100,000
-100,000
| -50% | -$2.34M |
|
|
KTWO
30
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.17M | 0.88% |
+140,000
| New | +$2.17M |
|
|
AXDX
31
DELISTED
Accelerate Diagnostics
AXDX
| $2.16M | 0.88% |
150,000
+25,000
| +20% | +$360K |
|
|
SPNC
32
DELISTED
Spectranetics Corp
SPNC
| $2.06M | 0.84% |
110,000
| – | – |
|
|
EPZM
33
DELISTED
Epizyme, Inc
EPZM
| $2.05M | 0.83% |
+200,000
| New | +$2.05M |
|
34
MacroGenics
MGNX
$112M
| $2.02M | 0.82% |
+75,000
| New | +$2.02M |
|
|
MDCO
35
DELISTED
Medicines Co
MDCO
| $2.02M | 0.82% |
+60,000
| New | +$2.02M |
|
|
XENT
36
DELISTED
Intersect ENT, Inc
XENT
| $1.94M | 0.79% |
+150,000
| New | +$1.94M |
|
37
Option Care Health
OPCH
$4.65B
| $1.91M | 0.78% |
+750,000
| New | +$1.91M |
|
|
RDUS
38
DELISTED
Radius Health, Inc.
RDUS
| $1.84M | 0.75% |
+50,000
| New | +$1.84M |
|
39
UnitedHealth
UNH
$281B
| $1.77M | 0.72% |
+12,500
| New | +$1.77M |
|
|
XLRN
40
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.7M | 0.69% |
50,000
-25,000
| -33% | -$850K |
|
|
ADAP
41
Adaptimmune Therapeutics
ADAP
$15.6M
| $1.63M | 0.66% |
200,000
-50,000
| -20% | -$408K |
|
|
PMC
42
DELISTED
PharMerica Corporation
PMC
| $1.6M | 0.65% |
+65,000
| New | +$1.6M |
|
43
Merus
MRUS
$4.98B
| $1.6M | 0.65% |
+200,000
| New | +$1.6M |
|
|
ADMS
44
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.51M | 0.62% |
100,000
-100,000
| -50% | -$1.51M |
|
45
Seres Therapeutics
MCRB
$166M
| $1.45M | 0.59% |
+50,000
| New | +$1.45M |
|
46
Cytokinetics
CYTK
$4.23B
| $1.42M | 0.58% |
150,000
-25,000
| -14% | -$237K |
|
|
AGTC
47
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.41M | 0.57% |
100,000
| – | – |
|
48
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.39M | 0.56% |
25,000
-35,000
| -58% | -$1.94M |
|
|
RVNC
49
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.36M | 0.55% |
+100,000
| New | +$1.36M |
|
50
Tandem Diabetes Care
TNDM
$845M
| $1.32M | 0.54% |
175,000
+25,000
| +17% | +$189K |
|